Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Here’s why it’s important to promptly address nausea and vomiting—and how you can navigate these common conditions during cancer treatme...
The study aims to improve the care of people with low-grade glioma by understanding more about the biology of the disease.
Vemurafenib (Zelboraf) and cobimetinib (Cotellic) may substantially delay, or even eliminate, the need for added treatments.
Roon reimagines how people diagnosed with glioblastomas navigate health information related to this type of cancer.
The results were extraordinary, with participants experiencing an average 90% reduction in tumor size.
Common and cheap epilepsy drug stops tumor growth in mice
Old Town Greenwood, Indiana, showed support for #TumorTakedownTailgate 2023 and the National Brain Tumor Society.
CU Cancer Center member Adam Green, MD, covers the symptoms, diagnosis, and treatment of pediatric brain tumors.
Targeted therapies can reduce the size and number of brain metastases; patients could then have better-tolerated radiation therapy.
New visualization tool allows researchers to compare tumor types and normal brain tissue and pinpoint cancer-promoting alterations.
Terminal brain cancer prompted Catherine Wreford Ledlow to return to the stage, with determination and grit.
UCSF researchers identify the cellular source of recurrent glioma
“Amazing Race” winners Catherine Wreford Ledlow and Craig Ramsay inspire resiliency when facing cancer.
Two studies found a vulnerability in gliomas—a type of brain tumors—that may open the door to new treatments for this cancer.
The CU Cancer Center was one of the clinical trial sites for Optune, which creates electrical fields that stop cancer cells from dividing.
Focusing on penetrating the blood-brain barrier in glioblastoma to more effectively deliver anti-cancer therapies.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.